National meeting about advanced molecular cancer diagnostics
Tuesday the 11th of June oncologist and pathologist from all the University Hospitals in Norway gathered at the Radiumhospital to discuss implementation of personalized medicine in cancer treatment.
The meeting was organized by the Division of Cancer Medicine at OUS to highlight the needs and challenges related to the advanced molecular diagnostics needed for implementation of personalized medicine in both clinic practice and clinical trials.
Published in Level 2 journals, first or last author from Oslo University Hospital.
Sheng X, Nenseth HZ, Qu S, Kuzu OF, Frahnow T, Simon L, Greene S, Zeng Q, Fazli L, Rennie PS, Mills IG, Danielsen H, Theis F, Patterson JB, Jin Y, Saatcioglu F(2024) Author Correction: IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling Nat Commun, 15(1), 6190 DOI 10.1038/s41467-024-50645-x, PubMed 39043728
Bretthauer M, Pilonis ND(2024) Brief sigmoidoscopy provides 21-year colorectal cancer risk reduction in men Lancet Gastroenterol Hepatol(in press) DOI 10.1016/S2468-1253(24)00199-7, PubMed 39038481
Amstutz A, Schönenberger CM, Speich B, Griessbach A, Schwenke JM, Glasstetter J, James S, Verkooijen HM, Nickolls B, Relton C, Hemkens LG, Chammartin F, Gerber F, Labhardt ND, Schandelmaier S, Briel M(2024) Characteristics, consent patterns, and challenges of randomized trials using the Trials within Cohorts (TwiCs) design A scoping review J Clin Epidemiol, 111469(in press) DOI 10.1016/j.jclinepi.2024.111469, PubMed 39032590